A press release said the investigation focuses on whether GlaxoSmithKline properly managed the Company’s 401(k) plan and whether certain administrators of the plan complied with their fiduciary duties to prudently manage the plan.
The law firm is asking current or former participants of the GlaxoSmithKline 401(k) plan to contact attorneys Michael I. Fistel Jr., Esq. or Marshall P. Dees, Esq. via email at email@example.com, or firstname.lastname@example.org, or via telephone at (888) 508-6832.
More about the firm’s investigations is at www.holzerlaw.com.
Last week, law firm Stull, Stull & Brody also announced it is investigating the drugmaker for potential ERISA violations (see Law Firm Probes Drugmaker for 401(k) Missteps).